Treatment Strategies in Colorectal Cancer Patients With Initially Unresectable Liver-only Metastases

~16 mi. (Almelo, Netherlands, +54 more cities)

Flevoziekenhuis

Colorectal Carcinoma

bevacizumab, +6 more drugs

chemotherapy, +1 more type

Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)

~22 mi. (Hengelo, Netherlands, +226 more cities)

Ziekenhuisgroep Twente ( Site 0469)

Prostate Adenocarcinoma

enzalutamide, +1 more drug

hormone therapy, +1 more type

Substantially Improving the Cure Rate of High-risk BRCA1-like Breast Cancer

~27 mi. (Enschede, Netherlands, +9 more cities)

Medical spectrum Twente

HER2 Negative, +1 more biomarker

Breast Carcinoma

carboplatin, +7 more drugs

chemotherapy, +2 more types

Phase 3 Study of Sitravatinib Plus Nivolumab vs Docetaxel in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer

~40 mi. (Zwolle, Netherlands, +206 more cities)

Isala

Non-Squamous Non-Small Cell Lung Carcinoma

nivolumab, +1 more drug

immunotherapy, +1 more type

A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer

~40 mi. (Zwolle, Netherlands, +209 more cities)

Isala Ziekenhuis Zwolle

ERBB2 Amplification, +1 more biomarker

Breast Carcinoma

ado-trastuzumab emtansine, +1 more drug

targeted therapy

Investigation of Radium-223 Dichloride (Xofigo), a Treatment That Gives Off Radiation That Helps Kill Cancer Cells, Compared to a Treatment That Inactivates Hormones (New Antihormonal Therapy, NAH) in Patients With Prostate Cancer That Has Spread to the Bone Getting Worse on or After Earlier NAH

~69 mi. (Münster, Germany, +122 more cities)

Universitätsklinikum Münster (UKM)

Prostate Adenocarcinoma

radium Ra 223 dichloride

radiation therapy

Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)

~69 mi. (Münster, Germany, +93 more cities)

Universitaetsklinikum Muenster ( Site 0516)

Bladder Carcinoma, +1 more condition

cisplatin, +4 more drugs

chemotherapy, +3 more types

A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)

~69 mi. (Harderwijk, Netherlands, +172 more cities)

Ziekenhuis St. Jansdal

RET Fusion

Non-Small Cell Lung Carcinoma

selpercatinib

targeted therapy

Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

~69 mi. (Münster, Germany, +158 more cities)

GEHO Muenster ( Site 0910)

Non-Small Cell Lung Carcinoma

olaparib, +4 more drugs

chemotherapy, +3 more types

Sacituzumab Govitecan in Primary HER2-negative Breast Cancer

~69 mi. (Münster, Germany, +94 more cities)

Universitätsklinikum Münster

HER2 Negative

Breast Carcinoma

sacituzumab govitecan

chemotherapy, +1 more type

Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)

~69 mi. (Münster, Germany, +126 more cities)

Universitaetsklinikum Muenster ( Site 0248)

Adenocarcinoma of the Gastroesophageal Junction, +1 more condition

FOLFOX regimen, +3 more drugs

chemotherapy, +2 more types

A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML)

~69 mi. (Münster, Germany, +127 more cities)

Universitaetsklinikum Muenster /ID# 215213

Acute Myeloid Leukemia

azacitidine, +2 more drugs

chemotherapy